ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 891,68
-0,19%
Dow Jones
44 873,28
0,71%
DAX
21 585,93
0,35%
Brent Oil
74,645
0,09%
Bitcoin
97 824,29
1,25%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC

  6. Arch Therapeutics Inc (QB) (ARTH) Cours

Arch Therapeutics Inc (QB)

Arch Therapeutics Inc (QB) (ARTH)

USOTC
0,1811
-0,02
(-9,95%)
Fermé 06 Février 10:00PM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,1811
Prix Achat
0,15
Prix Vente
0,50
Volume échangé
484
0,1811 Fourchette du Jour 0,193325
0,17 Plage de 52 semaines 3,4275
Cap du marché
804,874k
Clôture Veille
0,2011
Ouverture
0,193325
Dernière Transaction
2
@
0.20555
Dernière heure de transaction
Volume financier
US$ 91
VWAP
0,189005
Volume moyen (3 m)
8 359
Actions en circulation
4 444 364
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,11
Bénéfice par action (BPA)
-1,57
Chiffre d'affairess
76k
Bénéfice net
-6,98M

À propos de Arch Therapeutics Inc (QB)

Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform wit... Arch Therapeutics, Inc. is a biotechnology company developing a novel approach to stop bleeding (hemostasis), control leaking (sealant) and manage wounds during surgery, trauma and interventional care. Arch is developing products based on an innovative self-assembling barrier technology platform with the goal of making care faster and safer for patients. Arch's products authorized for commercial marketing are AC5 Advanced Wound System and AC5 Topical Hemostat. Arch's development stage product candidates include AC5-GTM and AC5 Surgical Hemostat, among others. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.archtherapeutics.com
Siège social
Carson City, Nevada, USA
Fondé
-
Arch Therapeutics Inc (QB) est coté dans le secteur Surgical,med Instr,apparatus de la OTCMarkets avec le ticker ARTH. Le dernier cours de clôture d'Arch Therapeutics (QB) était de US$0,20. Au cours de la dernière année, les actions de Arch Therapeutics (QB) ont été négociées dans une fourchette de prix de US$ 0,17 à US$ 3,4275.

Arch Therapeutics (QB) compte actuellement 4 444 364 actions en circulation. La capitalisation boursière d'Arch Therapeutics (QB) est de US$893 761,60 . Arch Therapeutics (QB) a un ratio cours/bénéfice (ratio PE) de -0.11.

ARTH Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

23 Janvier 2025
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

31 Décembre 2024
Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

13 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

07 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

04 Novembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Septembre 2024
Edgar (US Regulatory)

Insider Financial Publishes New Research On Three Promising Biotechs

Insider Financial, a leading research site for microcap companies, publishes new research on Arch Therapeutics Inc (OTCBB:ARTH), Medifirst Solutions Inc (OTCMKTS:MFST), and Cellceutix Corp...

16 Juillet 2016
InvestorsHub NewsWire

One Step Vending Corp. KOSK – 230% Growth and Over 150,000 Units Supplied

Miami, FL--(InvestorsHub NewsWire –July 14, 2016) - EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the...

14 Juillet 2016
InvestorsHub NewsWire

IPOs and Transactions: March 17 - 21

IPOs and Transactions: March 17 - 21 Last week's review of corporations, SEC form type and law firms PR Newswire NEW YORK, March 24, 2014 NEW YORK, March 24, 2014 /PRNewswire/ -- There were 56...

24 Mars 2014
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.00010.05524861878450.1810.230.1818600.18585112CS
40.0035251.985076728140.1775750.28990.170148250.20621018CS
12-0.0789-30.34615384620.260.30.1783590.20027176CS
26-0.7686-80.9308202590.94970.94970.1788750.32410003CS
52-2.9339-94.18619582663.1153.42750.1759940.65638162CS
156-23.0789-99.221410146223.26240.171042898.07286146CS
260-43.8189-99.588409090944520.1721451922.31673586CS

ARTH - Frequently Asked Questions (FAQ)

What is the current Arch Therapeutics (QB) share price?
The current share price of Arch Therapeutics (QB) is US$ 0,1811
How many Arch Therapeutics (QB) shares are in issue?
Arch Therapeutics (QB) has 4 444 364 shares in issue
What is the market cap of Arch Therapeutics (QB)?
The market capitalisation of Arch Therapeutics (QB) is USD 893,76k
What is the 1 year trading range for Arch Therapeutics (QB) share price?
Arch Therapeutics (QB) has traded in the range of US$ 0,17 to US$ 3,4275 during the past year
What is the PE ratio of Arch Therapeutics (QB)?
The price to earnings ratio of Arch Therapeutics (QB) is -0,11
What is the cash to sales ratio of Arch Therapeutics (QB)?
The cash to sales ratio of Arch Therapeutics (QB) is 10,53
What is the reporting currency for Arch Therapeutics (QB)?
Arch Therapeutics (QB) reports financial results in USD
What is the latest annual turnover for Arch Therapeutics (QB)?
The latest annual turnover of Arch Therapeutics (QB) is USD 76k
What is the latest annual profit for Arch Therapeutics (QB)?
The latest annual profit of Arch Therapeutics (QB) is USD -6,98M
What is the registered address of Arch Therapeutics (QB)?
The registered address for Arch Therapeutics (QB) is 769 BASQUE WAY, SUITE 300, CARSON CITY, NEVADA, 89706
What is the Arch Therapeutics (QB) website address?
The website address for Arch Therapeutics (QB) is www.archtherapeutics.com
Which industry sector does Arch Therapeutics (QB) operate in?
Arch Therapeutics (QB) operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MAPTMAPtelligent Inc (CE)
US$ 0,0003
(29 900,00%)
10k
VGTLVGTel Inc (CE)
US$ 0,0002
(19 900,00%)
4k
VGLSVG Life Sciences Inc (PK)
US$ 0,0001
(9 900,00%)
531,7k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0,0001
(9 900,00%)
100
JUVAFJuva Life Inc (CE)
US$ 0,0001
(9 900,00%)
10,75k
SHWZMedicine Man Technologies Inc (CE)
US$ 0,000001
(-100,00%)
12,36k
ELIQQElectriq Power Holdings Inc (CE)
US$ 0,0001
(-99,95%)
100
CCTLCoin Citadel (PK)
US$ 0,000001
(-99,50%)
200k
INNXInfinite Networks Corporation (CE)
US$ 0,000001
(-99,50%)
2,5k
WHENWorld Health Energy Holdings Inc (PK)
US$ 0,000001
(-99,20%)
1,05M
HMBLHUMBL Inc (PK)
US$ 0,0006
(-14,29%)
345,82M
GRLFGreen Leaf Innovations Inc (PK)
US$ 0,0002
(100,00%)
294,48M
CBDDCBD of Denver Inc (PK)
US$ 0,0002
(0,00%)
161,07M
BLLBBell Buckle Holdings Inc (PK)
US$ 0,0008
(60,00%)
153,87M
RDARRaadr Inc (PK)
US$ 0,00085
(-15,00%)
151,03M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

USOTC
ARTH
Arch Therapeutics (QB)
LSE
50AI
Hsbc Bk. 24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces